Anastasiia Russkikh - Infectious Diseases

Author Information

Anastasiia Russkikh is affiliated with the Federal State Budgetary Institution "National Medical Research Center of Phthisiopulmonology and Infectious Diseases" of the Ministry of Health of the Russian Federation, located in Moscow. Her work primarily focuses on infectious diseases, with a particular emphasis on tuberculosis and related respiratory conditions.

Research Contributions

Anastasiia Russkikh has made significant contributions to the field of infectious diseases, particularly in the study of tuberculosis and its treatment. Her research includes examining the effectiveness of broncho-alveolar lavage for pathogen detection in children with pulmonary tuberculosis, as well as investigating factors associated with culture conversion in adults treated for extensively drug-resistant tuberculosis. She has also explored the epidemiological and bacteriological characteristics of tuberculosis in various regions, including the Russian Arctic, and has contributed to understanding the impact of novel coronavirus infection.

Aliases

Anastasiia Russkikh is also known by the aliases A. E. Russkikh and A. Russkikh. These variations of her name appear in different publications and records.

Publication and Citation Metrics

Metric	Value
Total Papers	8
Total Citations	54
H-index	3

Publications:

The effectiveness of broncho-alveolar lavage for the pathogen detection in children with pulmonary tuberculosis

DOI: 10.1183/13993003.congress-2021.oa4206

Year: 2021

Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study.

DOI: 10.4081/monaldi.2021.1678

Year: 2021

Short course treatment of pulmonary tuberculosis patients suffering from multiple drug resistance. The current situation and future perspectives

DOI: 10.21292/2075-1230-2020-98-12-57-66

Year: 2021

Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts

DOI: 10.1183/13993003.congress-2020.1606

Year: 2020

Epidemiological and bacteriological characteristics of tuberculosis (TB) in the Russian Arctic (RA) region indigenous people and newcomers

DOI: 10.1183/13993003.congress-2020.1452

Year: 2020

Novel coronavirus infection

DOI: 10.21292/2075-1230-2020-98-4-6-14

Year: 2020

Endobronchial valve treatment for cavitary pulmonary diseases caused by non-tuberculosis mycobacteria

DOI: 10.1183/13993003.congress-2019.pa4586

Year: 2019

How Can Genomic Information Aid in Vaccine Development?

Why is the DTaP Vaccine Important?

How Effective Are Condoms in Preventing HIV?

What is Proteomics?

What is the DTaP Vaccine?

What is the Treatment for E. Coli Infection?

Why is Drug Resistance a Concern?

How is Strep Throat Diagnosed?

Why is Quarantine Necessary?

How Do Serological Tests Work?

Partnered Content Networks

Relevant Topics